Evidence map›Paper›PMID 32226577›Full record

ArticleInternational journal of clinical and experimental pathology2018

Erratum: Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells.

Fangfang Guo, Xueqi Fu, Jili Yang, Xueying Zhang, Dezhi Liu, Wenjuan Feng, Jinyu Liu, Jinhong Qi, Huifang Cao, Li Qi and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Fangfang GuoEdmond H. Fischer Signal Transduction Laboratory, School of Life Sciences, Jilin University Changchun 130012, Jilin, China.
Xueqi FuEdmond H. Fischer Signal Transduction Laboratory, School of Life Sciences, Jilin University Changchun 130012, Jilin, China.
Jili YangDepartment of Medical Oncology, Jilin Tumor Hospital Changchun, Jilin, China.
Xueying ZhangDepartment of Medical Oncology, Jilin Tumor Hospital Changchun, Jilin, China.
Dezhi LiuDepartment of Medical Oncology, Jilin Tumor Hospital Changchun, Jilin, China.
Wenjuan FengDepartment of Medical Oncology, Jilin Tumor Hospital Changchun, Jilin, China.
Jinyu LiuDepartment of Medical Oncology, Jilin Tumor Hospital Changchun, Jilin, China.
Jinhong QiDepartment of Medical Oncology, Jilin Tumor Hospital Changchun, Jilin, China.
Huifang CaoDepartment of Medical Oncology, Jilin Tumor Hospital Changchun, Jilin, China.
Li QiChaoyang District People's Hospital of Jilin Province Changchun 130000, Jilin, China.
Jingyuan RenDepartment of Otorhinolaryngology, Jilin Tumor Hospital Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article on p. 9621 in vol. 10, PMID: 31966840.].

Identifiers

PMID32226577
PMCPMC7090251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.